89 results
Page 3 of 5
8-K
EX-1.1
gy1qh77gxepspa
26 Aug 20
Ovid Therapeutics Announces Pricing of $50 Million Offering of Common Stock
4:10pm
424B5
skkbu9
26 Aug 20
Prospectus supplement for primary offering
4:07pm
8-K
leaigzg7v38 rvh9xh7d
13 Jul 20
Entry into a Material Definitive Agreement
7:06am
8-K
EX-99.1
cn7 n776vsmx8
1 Nov 19
Ovid Therapeutics Announces Senior Management Promotions in Preparation for Multiple Data Readouts Expected in 2020
8:23am
424B5
zus k9xacujtyhxedq45
7 Oct 19
Prospectus supplement for primary offering
9:35pm
424B5
s4d0zzy
7 Oct 19
Prospectus supplement for primary offering
9:33pm
8-K
EX-1.2
zgnt22s 5s3sgv1r
7 Oct 19
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
9:29pm
8-K
EX-1.1
s7l 84dhcafkt33
7 Oct 19
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
9:29pm